-
Polygodial and the TRPA1-to-TSLP Axis
2026-09-30
Polygodial offers a practical entry point for investigating TRPA1-dependent calcium signaling, NFAT activation, and epithelial inflammatory outputs. This thought-leadership analysis connects mechanistic evidence from nasal epithelial research with translational workflows for ion channel biology, sensory neurophysiology, and airway inflammation studies.
-
Pam3CSK4 TFA: TLR1/2 Assay Workflows
2026-09-30
Pam3CSK4 TFA is a defined TLR1/2 agonist for separating receptor-specific innate immune signaling from the complexity of whole-bacterium stimulation. This guide translates maternal–neonatal GBS findings into practical ex vivo workflows, cytokine readouts, controls, and troubleshooting strategies.
-
Light-Inducible RNA-Releasing Protein in Gene Therapy
2026-09-29
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translational level. Its compatibility with cell encapsulation and AAV delivery enabled light-regulated metabolic and retinal gene therapy in mice, while illustrating both the potential and the practical constraints of optogenetic treatment control.
-
PD0325901 Workflow for MEK–ERK Research
2026-09-29
PD0325901 provides a practical pharmacological switch for testing MEK–ERK signaling, linking rapid P-ERK suppression to cell-cycle and apoptosis readouts. This guide adapts the compound for oncology, xenograft, and APEX2–TERT research while emphasizing controls, formulation, and interpretation limits.
-
P101 Reduces Alcoholic Liver Lipid via AMPK
2026-09-28
A mouse study found that Lactiplantibacillus plantarum P101 reduced alcohol-associated hepatic lipid accumulation alongside AMPK activation, and that pharmacological AMPK inhibition weakened this response. Microbiota profiling and serum metabolomics further identified candidate gut–liver correlates, including stercobilinogen, that warrant causal testing.
-
HA Tag Peptide for Ubiquitination Assay Design
2026-09-27
The Influenza Hemagglutinin (HA) Peptide can support controlled recovery of tagged proteins in studies of ubiquitination and protein turnover. Learn how to use competitive elution thoughtfully, interpret a key NEDD4L–PRMT5 metastasis study, and design controls that separate binding from biology.
-
A-1331852: A Selective BCL-XL Inhibitor
2026-09-26
A-1331852 is a selective BCL-XL inhibitor used in preclinical apoptosis and cancer research. Product information reports cellular activity in the low-nanomolar range, while a separate breast-cancer study supports BH3-mimetic targeting of chemotherapy-induced senescent cells—not direct validation of A-1331852 in that setting.
-
Ibrutinib (PCI-32765) in BTK Assays
2026-09-26
Practical guidance for planning and interpreting cell-viability and signaling experiments with Ibrutinib (PCI-32765), including solubility, controls, and vendor-selection considerations. The article explains what the reported 0.5 nM BTK IC50 does—and does not—tell you when choosing SKU A3001 for B-cell research.
-
Chlorpromazine Workflows for Receptor and Cell Assays
2026-09-25
Use Chlorpromazine to probe dopamine-receptor pharmacology and antiemetic pathways with controlled, concentration-responsive workflows. A recent liver nanoparticle study offers a useful model for cell-resolved assay design—not evidence that chlorpromazine changes nanoparticle uptake.
-
FPH1 (BRD-6125) for Functional Hepatocyte Expansion
2026-09-25
FPH1 (BRD-6125) offers a practical way to promote hepatocyte proliferation while tracking functional markers such as albumin, CYP3A4, and AFP. This guide outlines a controlled culture workflow and explains how to interpret its use alongside, but separately from, light-regulated gene-expression research.
-
Nocodazole: Microtubule Inhibition in Cell Research
2026-09-24
Nocodazole is a reversible microtubule polymerization inhibitor that disrupts microtubule assembly through β-tubulin binding. In a Drosophila S2-cell infection model, nocodazole treatment reduced intracellular Spiroplasma eriocheiris, supporting a microtubule contribution without identifying the precise affected infection step.
-
Stiripentol Workflows for LDH and Lactate Research
2026-09-24
Use Stiripentol to test how LDH activity shapes lactate metabolism, from neuronal models to exploratory tumor–immune assays. This practical guide separates product-handling facts from proposed workflows and explains how to interpret metabolic and epigenetic readouts without assuming that LDH inhibition reproduces MPC effects.
-
Recombinant Mouse Sonic Hedgehog in Patterning
2026-09-23
Build more interpretable SHH experiments with a defined recombinant morphogen, from alkaline phosphatase validation to genital-tubercle organ culture. The workflow translates comparative mouse–guinea pig findings into practical choices for limb and brain patterning studies and congenital malformation research.
-
Human SAN-Plexus Assembloids Model Pacemaker Maturation
2026-09-23
This study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like organoids to model neural regulation of pacemaker maturation. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling axis that links cardiac innervation to pacemaker development and conduction.
-
Isoproterenol Sulfate Dihydrate in SAN Assays
2026-09-22
Isoproterenol sulfate dihydrate provides a controlled beta-adrenergic challenge for human sinoatrial node assembloid studies. This article explains how to distinguish acute receptor responsiveness from true pacemaker maturation and neuro-cardiac integration.